Clinical efficacy and safety of astragalus injection combined with ACEI/ARB in the treatment of diabetic kidney disease: Protocol for a systematic review and meta-analysis

Kidney disease is a common complication of diabetes and the main cause of end-stage renal disease. Astragalus (Huangqi) injection in combination with angiotensin-converting enzyme inhibitors/angiotensin receptor blockers (ACEI/ARBs) have been widely used for the treatment of diabetic kidney disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Zhiyue, Zhang, Qi, Liu, Le, Bao, Pengjie, Liu, Shilin, Song, Chaoqun, Yang, Wenbo, Nan, Zheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
3700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750634/
https://www.ncbi.nlm.nih.gov/pubmed/36626537
http://dx.doi.org/10.1097/MD.0000000000031490

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750634/
https://www.ncbi.nlm.nih.gov/pubmed/36626537
http://dx.doi.org/10.1097/MD.0000000000031490

Ejemplares similares